Understanding eGFR and uPCR is vital for managing IgA nephropathy to predict kidney health, guide treatment, and work effectively with healthcare providers in slowing disease progression.

Rocket Lab's estimated fair value is US$74.28 based on 2 Stage Free Cash Flow to Equity Current share price of US$80.48 suggests Rocket Lab is potentially trading close to its fair value Our fair ...

Your doctor says everything looks fine, but you still feel terrible. The problem might not be your health but how labs define “normal.” Understanding the difference between normal and optimal could ...

Labs calculate normal by testing everyone who walks through the door, including patients with undiagnosed conditions and chronic diseases. The middle 95 percent becomes the reference range, whether ...